
    
      This study was a multicenter, parallel, randomized, double-blind, placebo-controlled clinical
      trial designed to evaluate the efficacy ,safety, tolerance, and pharmacokinetics (PK) of
      different SHR-1314 dosing regimens in moderate to severe chronic plaque psoriasis in adults.
    
  